课题基金 / 基金详情

Control of Inflammatory Responses

Control of Inflammatory Responses
控制炎症反应
批准号:
255650
负责人:
Mak Tak W
金额:
$56.46万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-03-01 至 2017-03-01

项目摘要

项目成果

Mak Tak W的其他基金

相似基金

相关文献

中文摘要
翻译
我们身体抵御病原体入侵的第一道防线是炎症,这是由先天免疫系统的细胞介导的。然而,当这些先天免疫细胞发挥其有益的功能来清除病原体时
英文摘要
One of our bodies' first lines of defence against invading pathogens is a process called inflammation, which is mediated by cells of the innate immune system. However, when these innate immune cells carry out their beneficial functions to remove pathogens
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The roles of cholinergic T cells in immunosurveillance and immunotherapy of liver cancer.
  • 批准号:
    470085
  • 项目类别:
    Operating Grants
  • 资助金额:
    $75.24万
  • 财政年份:
    2022
  • 负责人:
    Mak Tak W
  • 依托单位:
Therapeutic targeting of epigenetic regulators in hematological malignancies
  • 批准号:
    462733
  • 项目类别:
    Operating Grants
  • 资助金额:
    $75.24万
  • 财政年份:
    2022
  • 负责人:
    Mak Tak W
  • 依托单位:
Cholinergic Control of Immune Responses in Health and Autoimmune Disease: Mechanisms and Novel Therapeutic Opportunities
  • 批准号:
    452786
  • 项目类别:
    Operating Grants
  • 资助金额:
    $75.24万
  • 财政年份:
    2021
  • 负责人:
    Mak Tak W
  • 依托单位:
CIHR Gold Leaf Prize for Discovery
海外基金